Clinical trial

A Randomised Open Controlled Parallel Group Study Comparing Norspan and Tramadol

NCT00399178 · Mundipharma AB, Industry · Completed

Key facts

NCT number NCT00399178
Title A Randomised Open Controlled Parallel Group Study Comparing Norspan and Tramadol
Official title A Randomised Open Controlled Parallel Group Multicenter Study to Evaluate the Efficacy and Safety of Norspan Versus Tiparol Retard in Subjects With Chronic Moderate to Severe OA Pain of the Hip and/or Knee.
Lead sponsor Mundipharma AB, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Osteoarthritis
Intervention type Drug
Interventions Transdermal delivery system
Enrollment 160
Start date Nov 1, 2006
Completion Jun 1, 2007
First posted Nov 14, 2006
Last update posted Aug 17, 2007
Countries Sweden

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies